As of 2024-12-11, the Relative Valuation of Vincerx Pharma Inc (VINC) is (18.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.21 USD, the upside of Vincerx Pharma Inc based on Relative Valuation is -8804.5%.
The range of the Relative Valuation is (17.49) - (16.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 31.7x | 26.7x |
| Forward P/E multiples | 19.2x - 20.3x | 19.8x |
| Fair Price | (17.49) - (16.32) | (18.71) |
| Upside | -8240.4% - -7693.2% | -8804.5% |
| Date | P/E |
| 2024-12-10 | -0.27 |
| 2024-12-09 | -0.27 |
| 2024-12-06 | -0.25 |
| 2024-12-05 | -0.26 |
| 2024-12-04 | -0.30 |
| 2024-12-03 | -0.32 |
| 2024-12-02 | -0.36 |
| 2024-11-29 | -0.35 |
| 2024-11-27 | -0.33 |
| 2024-11-26 | -0.32 |
| 2024-11-25 | -0.32 |
| 2024-11-22 | -0.31 |
| 2024-11-21 | -0.32 |
| 2024-11-20 | -0.34 |
| 2024-11-19 | -0.34 |
| 2024-11-18 | -0.34 |
| 2024-11-15 | -0.37 |
| 2024-11-14 | -0.37 |
| 2024-11-13 | -0.40 |
| 2024-11-12 | -0.42 |
| 2024-11-11 | -0.44 |
| 2024-11-08 | -0.41 |
| 2024-11-07 | -0.40 |
| 2024-11-06 | -0.41 |
| 2024-11-05 | -0.43 |
| 2024-11-04 | -0.44 |
| 2024-11-01 | -0.45 |
| 2024-10-31 | -0.43 |
| 2024-10-30 | -0.43 |
| 2024-10-29 | -0.46 |
| 2024-10-28 | -0.46 |
| 2024-10-25 | -0.47 |
| 2024-10-24 | -0.48 |
| 2024-10-23 | -0.45 |
| 2024-10-22 | -0.48 |
| 2024-10-21 | -0.47 |
| 2024-10-18 | -0.47 |
| 2024-10-17 | -0.47 |
| 2024-10-16 | -0.49 |
| 2024-10-15 | -0.47 |
| 2024-10-14 | -0.50 |
| 2024-10-11 | -0.49 |
| 2024-10-10 | -0.48 |
| 2024-10-09 | -0.50 |
| 2024-10-08 | -0.51 |
| 2024-10-07 | -0.87 |
| 2024-10-04 | -0.91 |
| 2024-10-03 | -0.89 |
| 2024-10-02 | -0.86 |
| 2024-10-01 | -0.85 |